Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Atea Pharmaceuticals shares are trading lower after the company announced the outcome of the global Phase 3 SUNRISE-3 trial evaluating bemnifosbuvir for the treatment of COVID-19 and found that the trial did not meet the primary endpoint.

Author: Benzinga Newsdesk | September 13, 2024 07:47am

Posted In: AVIR